While IL-17RA, in part via IL-17A, was previously determined to regulate obesity-dependent NAFLD, our novel data show that hepatic IL-17RA expression is actually increased during MCDD-induced NAFLD [3]. The gene discussed is IL17RA; the disease is metabolic dysfunction-associated steatotic liver disease.